Patents by Inventor Clive Mason

Clive Mason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALARM NOTIFICATION SYSTEM
    Publication number: 20160005301
    Abstract: An alarm notification system comprising: a central server; the central server configured to monitor the status of one or more remote alarms, and in the event of the status of a first remote alarm changing, generating an alert to send to a first remote device; the central server further configured to determine if the first remote device is connected to the alarm notification system by a persistent connection, and in the event that the first remote device is connect via persistent connection sending an alarm notification message via the persistent connection; and in the event that the first remote device is not connected via a persistent connection sending an alarm notification message via a push notification service.
    Type: Application
    Filed: February 19, 2014
    Publication date: January 7, 2016
    Inventors: Clive Mason, Mark Young
  • Triamide-substituted heterobicyclic compounds
    Patent number: 7482368
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R1-R8 are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
    Type: Grant
    Filed: August 2, 2005
    Date of Patent: January 27, 2009
    Assignee: Pfizer Inc
    Inventors: Peter Bertinato, Brian Bronk, Alan E. Blize, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason
  • Triamide-substituted heterobicyclic compounds
    Patent number: 7348355
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R1-R8 are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
    Type: Grant
    Filed: February 10, 2006
    Date of Patent: March 25, 2008
    Assignee: Pfizer Inc.
    Inventors: Peter Bertinato, Alan E. Blize, Brian Bronk, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason
  • Triamide-substituted heterobicyclic compounds
    Publication number: 20060194772
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R1-R8 are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
    Type: Application
    Filed: February 10, 2006
    Publication date: August 31, 2006
    Inventors: Peter Bertinato, Alan Blize, Brian Bronk, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason
  • Triamide-substituted heterobicyclic compounds
    Publication number: 20050288335
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R1-R8 are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
    Type: Application
    Filed: August 2, 2005
    Publication date: December 29, 2005
    Inventors: Peter Bertinato, Alan Blize, Brian Bronk, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason
  • Triamide-substituted heterobicyclic compounds
    Patent number: 6979692
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R1-R8 are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
    Type: Grant
    Filed: August 13, 2003
    Date of Patent: December 27, 2005
    Assignee: Pfizer Inc.
    Inventors: Peter Bertinato, Alan E. Blize, Brian S. Bronk, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason
  • Triamide-substituted heterobicyclic compounds
    Patent number: 6949572
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R1-R8 are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
    Type: Grant
    Filed: August 13, 2003
    Date of Patent: September 27, 2005
    Assignee: Pfizer Inc.
    Inventors: Peter Bertinato, Brian S. Bronk, Alan E. Blize, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason
  • Triamide-substituted heterobicyclic compounds
    Publication number: 20050080108
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R1—R8 are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
    Type: Application
    Filed: August 13, 2003
    Publication date: April 14, 2005
    Inventors: Peter Bertinato, Alan Blize, Brian Bronk, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason
  • Triamide-substituted heterobicyclic compounds
    Publication number: 20040087625
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 1
    Type: Application
    Filed: August 13, 2003
    Publication date: May 6, 2004
    Applicant: Pfizer Inc
    Inventors: Peter Bertinato, Brian S. Bronk, Alan E. Blize, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason
  • Triamide-substituted heterobicyclic compounds
    Patent number: 6720351
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 wherein R1-R8 are as defined in the specification, as well as pharmaceutical compositions and uses thereof, and processes for preparing the compounds. The compounds of the invention are useful for the treatment of obesity and lipid disorders.
    Type: Grant
    Filed: June 20, 2002
    Date of Patent: April 13, 2004
    Assignee: Pfizer Inc.
    Inventors: Peter Bertinato, Alan E. Blize, Brian S. Bronk, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason
  • Triamide-substituted heterobicyclic compounds
    Publication number: 20030187053
    Abstract: The invention relates to triamide MTP/ApoB inhibitors of the formula 1 1
    Type: Application
    Filed: June 20, 2002
    Publication date: October 2, 2003
    Applicant: Pfizer Inc.
    Inventors: Peter Bertinato, Alan E. Blize, Brian S. Bronk, Hengmiao Cheng, Jin Li, Hiep Huatan, Clive Mason